World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02709876
Date of registration: 26/02/2016
Prospective Registration: No
Primary sponsor: Stem Cells Arabia
Public title: Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis Pigmentosa
Scientific title:
Date of first enrolment: April 2014
Target sample size: 50
Recruitment status: Active, not recruiting
URL:  https://clinicaltrials.gov/show/NCT02709876
Study type:  Interventional
Study design:  Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  Phase 1/Phase 2
Countries of recruitment
Jordan
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- Retinitis pigmentosa patients diagnosed by ophthalmologists

- Visual acuity (measured with ETDRS) less than or equal to 20/70 and visual field below
30° central in both eyes.

- Best corrected visual acuity less than 6/120 by Snellen visual acuity chart

Exclusion Criteria:

- Other eye conditions that could mask the interpretation of the results

- Unable to return for follow up

- Underlying diseases including asthma, heart failure, myocardial infarction, liver
failure, renal failure

- Pregnant and lactating women



Age minimum: 18 Years
Age maximum: 55 Years
Gender: All
Health Condition(s) or Problem(s) studied
Retinitis Pigmentosa
Intervention(s)
Biological: Stem Cell Transplantation
Primary Outcome(s)
ETDRS Visual acuity change [Time Frame: 12 months from baseline]
Secondary Outcome(s)
Quality of Life: Questionnaire VFQ-25 (Visual Function Questionnaire-25) [Time Frame: 12 months from baseline]
Color Vision: Ishihara Color Test [Time Frame: 12 months from baseline]
Contrast sensitivity: CSV-1000E [Time Frame: 12 months from baseline]
Secondary ID(s)
SCA-RP1
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history